

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | pattern specification involved in kidney development (GO:0061004) | 8.75178341 |
| 2 | intestinal cholesterol absorption (GO:0030299) | 8.24801639 |
| 3 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 7.11689553 |
| 4 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 6.99666390 |
| 5 | alpha-linolenic acid metabolic process (GO:0036109) | 6.98363993 |
| 6 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 6.90755599 |
| 7 | acyl-CoA biosynthetic process (GO:0071616) | 6.89959998 |
| 8 | thioester biosynthetic process (GO:0035384) | 6.89959998 |
| 9 | regulation of sequestering of triglyceride (GO:0010889) | 6.73814503 |
| 10 | cholesterol catabolic process (GO:0006707) | 6.69569184 |
| 11 | sterol catabolic process (GO:0016127) | 6.69569184 |
| 12 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 6.62433847 |
| 13 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 6.39999796 |
| 14 | regulation of phospholipid biosynthetic process (GO:0071071) | 6.39856451 |
| 15 | positive regulation of p38MAPK cascade (GO:1900745) | 6.39114288 |
| 16 | phospholipid homeostasis (GO:0055091) | 6.30931942 |
| 17 | pyrimidine-containing compound transmembrane transport (GO:0072531) | 6.13565295 |
| 18 | linoleic acid metabolic process (GO:0043651) | 5.86439659 |
| 19 | mammary gland epithelial cell differentiation (GO:0060644) | 5.79609783 |
| 20 | fatty acid transmembrane transport (GO:1902001) | 5.78117262 |
| 21 | intestinal absorption (GO:0050892) | 5.75702872 |
| 22 | ectoderm development (GO:0007398) | 5.53407152 |
| 23 | ceramide catabolic process (GO:0046514) | 5.36950140 |
| 24 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 5.36673897 |
| 25 | transcytosis (GO:0045056) | 5.28731632 |
| 26 | phagocytosis, recognition (GO:0006910) | 5.28193479 |
| 27 | carnitine shuttle (GO:0006853) | 5.21091660 |
| 28 | negative regulation of protein kinase B signaling (GO:0051898) | 5.20290847 |
| 29 | low-density lipoprotein particle clearance (GO:0034383) | 5.14082744 |
| 30 | biotin metabolic process (GO:0006768) | 5.12722762 |
| 31 | fatty-acyl-CoA metabolic process (GO:0035337) | 5.11851249 |
| 32 | mitochondrial calcium ion transport (GO:0006851) | 5.00438804 |
| 33 | positive regulation of osteoblast proliferation (GO:0033690) | 5.00185006 |
| 34 | tooth mineralization (GO:0034505) | 4.95843450 |
| 35 | segment specification (GO:0007379) | 4.90990731 |
| 36 | positive regulation of macrophage cytokine production (GO:0060907) | 4.87261186 |
| 37 | * lactation (GO:0007595) | 4.85848860 |
| 38 | nucleoside transmembrane transport (GO:1901642) | 4.82643455 |
| 39 | negative regulation of endothelial cell proliferation (GO:0001937) | 4.74203246 |
| 40 | regulation of p38MAPK cascade (GO:1900744) | 4.50696214 |
| 41 | regulation of penile erection (GO:0060405) | 4.48087573 |
| 42 | nucleobase catabolic process (GO:0046113) | 4.41650636 |
| 43 | GDP-mannose metabolic process (GO:0019673) | 4.40805808 |
| 44 | regulation of apoptotic cell clearance (GO:2000425) | 4.39798110 |
| 45 | acetyl-CoA metabolic process (GO:0006084) | 4.34456966 |
| 46 | regulation of triglyceride biosynthetic process (GO:0010866) | 4.30940960 |
| 47 | embryonic process involved in female pregnancy (GO:0060136) | 4.21381405 |
| 48 | response to phenylpropanoid (GO:0080184) | 4.19404337 |
| 49 | triglyceride biosynthetic process (GO:0019432) | 4.18418035 |
| 50 | O-glycan processing (GO:0016266) | 4.16434521 |
| 51 | N-acetylneuraminate metabolic process (GO:0006054) | 4.14466019 |
| 52 | lipid storage (GO:0019915) | 4.12226924 |
| 53 | * secretion by tissue (GO:0032941) | 4.11525596 |
| 54 | response to host immune response (GO:0052572) | 4.10805273 |
| 55 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.10805273 |
| 56 | regulation of macrophage cytokine production (GO:0010935) | 4.10169218 |
| 57 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 4.05514227 |
| 58 | long-chain fatty acid transport (GO:0015909) | 4.03929700 |
| 59 | tricarboxylic acid metabolic process (GO:0072350) | 4.03292169 |
| 60 | regulation of triglyceride metabolic process (GO:0090207) | 4.00899244 |
| 61 | neutral lipid biosynthetic process (GO:0046460) | 4.00634347 |
| 62 | acylglycerol biosynthetic process (GO:0046463) | 4.00634347 |
| 63 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.96947502 |
| 64 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 3.96348702 |
| 65 | folic acid transport (GO:0015884) | 3.95010176 |
| 66 | Golgi transport vesicle coating (GO:0048200) | 3.89839333 |
| 67 | COPI coating of Golgi vesicle (GO:0048205) | 3.89839333 |
| 68 | positive regulation of reactive oxygen species metabolic process (GO:2000379) | 3.88922696 |
| 69 | growth hormone receptor signaling pathway (GO:0060396) | 3.84901390 |
| 70 | carnitine transmembrane transport (GO:1902603) | 3.83359550 |
| 71 | glutathione biosynthetic process (GO:0006750) | 3.79797978 |
| 72 | regulation of cholesterol storage (GO:0010885) | 3.79689009 |
| 73 | negative regulation of lipid catabolic process (GO:0050995) | 3.79661980 |
| 74 | negative regulation of epithelial cell differentiation (GO:0030857) | 3.78760454 |
| 75 | positive regulation of lipid storage (GO:0010884) | 3.77766518 |
| 76 | coenzyme A biosynthetic process (GO:0015937) | 3.72008576 |
| 77 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.71308098 |
| 78 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.71130528 |
| 79 | triglyceride catabolic process (GO:0019433) | 3.70633970 |
| 80 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.68915805 |
| 81 | response to host (GO:0075136) | 3.65288856 |
| 82 | response to host defenses (GO:0052200) | 3.65288856 |
| 83 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.65288856 |
| 84 | nucleoside transport (GO:0015858) | 3.63788055 |
| 85 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.62956265 |
| 86 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.62956265 |
| 87 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.59502413 |
| 88 | cellular carbohydrate biosynthetic process (GO:0034637) | 3.58625038 |
| 89 | fatty acid transport (GO:0015908) | 3.57772097 |
| 90 | valine metabolic process (GO:0006573) | 3.55982217 |
| 91 | galactose metabolic process (GO:0006012) | 3.55580957 |
| 92 | regulation of clathrin-mediated endocytosis (GO:2000369) | 3.54051166 |
| 93 | regulation of vasculogenesis (GO:2001212) | 3.49814200 |
| 94 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 3.49210719 |
| 95 | carnitine transport (GO:0015879) | 3.48964521 |
| 96 | amino-acid betaine transport (GO:0015838) | 3.48964521 |
| 97 | regulation of execution phase of apoptosis (GO:1900117) | 3.48813151 |
| 98 | regulation of endothelial cell differentiation (GO:0045601) | 3.44598710 |
| 99 | * body fluid secretion (GO:0007589) | 3.44574948 |
| 100 | pentose-phosphate shunt (GO:0006098) | 3.40257310 |
| 101 | acylglycerol catabolic process (GO:0046464) | 3.37143993 |
| 102 | neutral lipid catabolic process (GO:0046461) | 3.37143993 |
| 103 | positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:00360 | 3.36534776 |
| 104 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.35824365 |
| 105 | copper ion transport (GO:0006825) | 3.33358606 |
| 106 | purine nucleobase metabolic process (GO:0006144) | 3.28581887 |
| 107 | branched-chain amino acid metabolic process (GO:0009081) | 3.27494677 |
| 108 | positive regulation of chemokine secretion (GO:0090197) | 3.27098995 |
| 109 | negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556) | 3.24123268 |
| 110 | mitochondrion distribution (GO:0048311) | 3.23687402 |
| 111 | cellular response to growth hormone stimulus (GO:0071378) | 3.23196037 |
| 112 | sphingolipid catabolic process (GO:0030149) | 3.22625312 |
| 113 | temperature homeostasis (GO:0001659) | 3.22403800 |
| 114 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 3.19814898 |
| 115 | branched-chain amino acid catabolic process (GO:0009083) | 3.18608533 |
| 116 | negative regulation of fatty acid transport (GO:2000192) | 3.16257815 |
| 117 | oligosaccharide metabolic process (GO:0009311) | 3.15011376 |
| 118 | acyl-CoA metabolic process (GO:0006637) | 3.14957260 |
| 119 | thioester metabolic process (GO:0035383) | 3.14957260 |
| 120 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.14808682 |
| 121 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.14808682 |
| 122 | adhesion of symbiont to host (GO:0044406) | 3.13549251 |
| 123 | heme transport (GO:0015886) | 3.13108172 |
| 124 | regulation of fatty acid oxidation (GO:0046320) | 3.11961846 |
| 125 | localization within membrane (GO:0051668) | 3.11766938 |
| 126 | regulation of triglyceride catabolic process (GO:0010896) | 3.11011220 |
| 127 | intracellular lipid transport (GO:0032365) | 3.08415755 |
| 128 | white fat cell differentiation (GO:0050872) | 3.07351853 |
| 129 | steroid catabolic process (GO:0006706) | 3.05538376 |
| 130 | triglyceride metabolic process (GO:0006641) | 3.05332280 |
| 131 | proximal/distal pattern formation (GO:0009954) | 3.03249527 |
| 132 | NADPH regeneration (GO:0006740) | 3.01355058 |
| 133 | zinc ion transport (GO:0006829) | 3.00317314 |
| 134 | angiogenesis involved in wound healing (GO:0060055) | 3.00107829 |
| 135 | negative regulation of lipid storage (GO:0010888) | 2.96159985 |
| 136 | regulation of lipid storage (GO:0010883) | 2.94026288 |
| 137 | regulation of chemokine secretion (GO:0090196) | 2.93005790 |
| 138 | negative regulation of cell fate commitment (GO:0010454) | 2.91441002 |
| 139 | negative regulation of execution phase of apoptosis (GO:1900118) | 2.88514174 |
| 140 | membrane lipid catabolic process (GO:0046466) | 2.87653493 |
| 141 | acylglycerol metabolic process (GO:0006639) | 2.85520913 |
| 142 | hemidesmosome assembly (GO:0031581) | 2.84194495 |
| 143 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.83774031 |
| 144 | coenzyme A metabolic process (GO:0015936) | 2.83504268 |
| 145 | positive regulation of histone deacetylation (GO:0031065) | 2.83213704 |
| 146 | neutral lipid metabolic process (GO:0006638) | 2.81549163 |
| 147 | short-chain fatty acid metabolic process (GO:0046459) | 2.81018650 |
| 148 | detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580) | 2.79785165 |
| 149 | acrosome assembly (GO:0001675) | 2.75785916 |
| 150 | regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664) | 2.68760639 |
| 151 | nucleoside diphosphate biosynthetic process (GO:0009133) | 2.67207604 |
| 152 | peptide biosynthetic process (GO:0043043) | 2.57498642 |
| 153 | negative regulation of leukocyte migration (GO:0002686) | 2.55171351 |
| 154 | ether lipid metabolic process (GO:0046485) | 2.52523599 |
| 155 | one-carbon metabolic process (GO:0006730) | 2.48650657 |
| 156 | digestive system process (GO:0022600) | 2.48283064 |
| 157 | positive regulation of macrophage activation (GO:0043032) | 2.46132266 |
| 158 | detection of molecule of bacterial origin (GO:0032490) | 2.45602685 |
| 159 | citrulline biosynthetic process (GO:0019240) | 2.45107558 |
| 160 | oligosaccharide biosynthetic process (GO:0009312) | 10.5365829 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 6.85482985 |
| 2 | * STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 6.67574896 |
| 3 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 4.57456703 |
| 4 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.23977000 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.80259628 |
| 6 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 3.79222337 |
| 7 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 3.56248013 |
| 8 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.99946765 |
| 9 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.89665512 |
| 10 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 2.86720899 |
| 11 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.84207256 |
| 12 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.74787846 |
| 13 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.67989821 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.54700810 |
| 15 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.48780223 |
| 16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.45075449 |
| 17 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.18862087 |
| 18 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.13433745 |
| 19 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.08897901 |
| 20 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.03876607 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.02948935 |
| 22 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 2.01730030 |
| 23 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.00045282 |
| 24 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.98227698 |
| 25 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86127951 |
| 26 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 1.83662918 |
| 27 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.81199335 |
| 28 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.77819634 |
| 29 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.75296404 |
| 30 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.69279686 |
| 31 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.67739642 |
| 32 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.63787220 |
| 33 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.63173144 |
| 34 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.56591723 |
| 35 | RXR_22108803_ChIP-Seq_LS180_Human | 1.54787164 |
| 36 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.49100767 |
| 37 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.44885682 |
| 38 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.44668943 |
| 39 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.44276797 |
| 40 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.43799293 |
| 41 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.41800799 |
| 42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.40745799 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.37559050 |
| 44 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.36432666 |
| 45 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.34978488 |
| 46 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.31430655 |
| 47 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.31389452 |
| 48 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.30495996 |
| 49 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.30389884 |
| 50 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.29240644 |
| 51 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29117028 |
| 52 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.28593784 |
| 53 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.27876336 |
| 54 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.26372310 |
| 55 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.25812958 |
| 56 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25272471 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.24473224 |
| 58 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.22980658 |
| 59 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.21350190 |
| 60 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.20664477 |
| 61 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.20479808 |
| 62 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.19973615 |
| 63 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.19867667 |
| 64 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.18831035 |
| 65 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.18276274 |
| 66 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.17043390 |
| 67 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.17043390 |
| 68 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.16540245 |
| 69 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.15455614 |
| 70 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.14319862 |
| 71 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.14297168 |
| 72 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14174287 |
| 73 | GATA1_22025678_ChIP-Seq_K562_Human | 1.13279398 |
| 74 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.12721086 |
| 75 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12594490 |
| 76 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.12531361 |
| 77 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.12212405 |
| 78 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.09837753 |
| 79 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.08330864 |
| 80 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.06291747 |
| 81 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.05792658 |
| 82 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05548094 |
| 83 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.04521394 |
| 84 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 1.03681752 |
| 85 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03128191 |
| 86 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.02027647 |
| 87 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01639279 |
| 88 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.01461944 |
| 89 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.01167648 |
| 90 | PU1_27457419_Chip-Seq_LIVER_Mouse | 1.00260175 |
| 91 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.99975254 |
| 92 | LMO2_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.98449440 |
| 93 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.96336556 |
| 94 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.96189635 |
| 95 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.95989201 |
| 96 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.95545504 |
| 97 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.93946230 |
| 98 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.93937069 |
| 99 | ATF3_27146783_Chip-Seq_COLON_Human | 0.93820343 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.93529053 |
| 101 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.93307386 |
| 102 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92954499 |
| 103 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.92906184 |
| 104 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90933549 |
| 105 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.90498514 |
| 106 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.89264716 |
| 107 | GATA1_19941826_ChIP-Seq_K562_Human | 0.88924503 |
| 108 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.88227935 |
| 109 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.87220707 |
| 110 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.86859820 |
| 111 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.85535419 |
| 112 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.85303746 |
| 113 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.85193306 |
| 114 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.83750383 |
| 115 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.83451509 |
| 116 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.82647843 |
| 117 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.82281632 |
| 118 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.81606020 |
| 119 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.81450174 |
| 120 | CBP_21632823_ChIP-Seq_H3396_Human | 0.81404946 |
| 121 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.81368409 |
| 122 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.81138981 |
| 123 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.79514343 |
| 124 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.78809885 |
| 125 | NFYA_21822215_ChIP-Seq_K562_Human | 0.78606924 |
| 126 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78458104 |
| 127 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.78278697 |
| 128 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.77996857 |
| 129 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77913352 |
| 130 | CBX2_22325352_ChIP-Seq_293T-Rex_Human | 0.77623703 |
| 131 | KDM2B_26808549_Chip-Seq_K562_Human | 0.77556378 |
| 132 | FLI1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.76651624 |
| 133 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76233182 |
| 134 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.76178382 |
| 135 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.76105789 |
| 136 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.75852818 |
| 137 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75764240 |
| 138 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.75325122 |
| 139 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.74445522 |
| 140 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.74445522 |
| 141 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.74011620 |
| 142 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.73991496 |
| 143 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.73901139 |
| 144 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.73657184 |
| 145 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.70724639 |
| 146 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.70449881 |
| 147 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.70164980 |
| 148 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.69383552 |
| 149 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.69331339 |
| 150 | CHD1_26751641_Chip-Seq_LNCaP_Human | 0.69196538 |
| 151 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.69048666 |
| 152 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.68394693 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003136_yellow_coat_color | 4.81394787 |
| 2 | MP0010234_abnormal_vibrissa_follicle | 4.41856813 |
| 3 | MP0002254_reproductive_system_inflammat | 3.78820225 |
| 4 | MP0000627_abnormal_mammary_gland | 3.28341945 |
| 5 | MP0004130_abnormal_muscle_cell | 3.23659014 |
| 6 | MP0003303_peritoneal_inflammation | 3.23585181 |
| 7 | MP0005083_abnormal_biliary_tract | 2.99107611 |
| 8 | MP0003300_gastrointestinal_ulcer | 2.89485373 |
| 9 | MP0005670_abnormal_white_adipose | 2.84404248 |
| 10 | MP0004019_abnormal_vitamin_homeostasis | 2.78166947 |
| 11 | MP0004147_increased_porphyrin_level | 2.53318886 |
| 12 | MP0003011_delayed_dark_adaptation | 2.44074662 |
| 13 | MP0001873_stomach_inflammation | 2.41839122 |
| 14 | MP0003705_abnormal_hypodermis_morpholog | 2.40054071 |
| 15 | MP0005666_abnormal_adipose_tissue | 2.27268693 |
| 16 | MP0004185_abnormal_adipocyte_glucose | 2.04660937 |
| 17 | * MP0001881_abnormal_mammary_gland | 10.8143885 |
| 18 | MP0002796_impaired_skin_barrier | 1.94375475 |
| 19 | MP0005360_urolithiasis | 1.87163076 |
| 20 | MP0004043_abnormal_pH_regulation | 1.79353093 |
| 21 | MP0004264_abnormal_extraembryonic_tissu | 1.76557012 |
| 22 | MP0005645_abnormal_hypothalamus_physiol | 1.69717314 |
| 23 | MP0005375_adipose_tissue_phenotype | 1.66377199 |
| 24 | MP0005410_abnormal_fertilization | 1.60846176 |
| 25 | MP0005085_abnormal_gallbladder_physiolo | 1.57454900 |
| 26 | MP0004272_abnormal_basement_membrane | 1.54568111 |
| 27 | MP0010329_abnormal_lipoprotein_level | 1.53434473 |
| 28 | MP0000013_abnormal_adipose_tissue | 1.42862710 |
| 29 | MP0001879_abnormal_lymphatic_vessel | 1.38846527 |
| 30 | MP0002098_abnormal_vibrissa_morphology | 1.38338963 |
| 31 | MP0002118_abnormal_lipid_homeostasis | 1.36886387 |
| 32 | MP0008438_abnormal_cutaneous_collagen | 1.31033046 |
| 33 | MP0000678_abnormal_parathyroid_gland | 1.28900181 |
| 34 | MP0008004_abnormal_stomach_pH | 1.28190098 |
| 35 | MP0003724_increased_susceptibility_to | 1.28026772 |
| 36 | MP0005076_abnormal_cell_differentiation | 1.22713515 |
| 37 | MP0009278_abnormal_bone_marrow | 1.20988536 |
| 38 | MP0005058_abnormal_lysosome_morphology | 1.20558612 |
| 39 | MP0001664_abnormal_digestion | 1.17928134 |
| 40 | MP0001666_abnormal_nutrient_absorption | 1.10263026 |
| 41 | MP0009764_decreased_sensitivity_to | 1.05358173 |
| 42 | MP0002971_abnormal_brown_adipose | 1.03718383 |
| 43 | MP0000003_abnormal_adipose_tissue | 1.03235520 |
| 44 | MP0002396_abnormal_hematopoietic_system | 1.00802223 |
| 45 | MP0003566_abnormal_cell_adhesion | 0.99990454 |
| 46 | MP0005501_abnormal_skin_physiology | 0.96320321 |
| 47 | MP0005275_abnormal_skin_tensile | 0.95040550 |
| 48 | MP0000377_abnormal_hair_follicle | 0.93990674 |
| 49 | MP0005448_abnormal_energy_balance | 0.92120887 |
| 50 | MP0002970_abnormal_white_adipose | 0.89012529 |
| 51 | MP0001663_abnormal_digestive_system | 0.88900411 |
| 52 | MP0002009_preneoplasia | 0.87994290 |
| 53 | MP0005164_abnormal_response_to | 0.87933968 |
| 54 | MP0003448_altered_tumor_morphology | 0.87066873 |
| 55 | MP0005334_abnormal_fat_pad | 0.86930071 |
| 56 | MP0009765_abnormal_xenobiotic_induced | 0.86251635 |
| 57 | MP0010678_abnormal_skin_adnexa | 0.86030185 |
| 58 | MP0005171_absent_coat_pigmentation | 0.85458555 |
| 59 | MP0001851_eye_inflammation | 0.85294091 |
| 60 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.85185324 |
| 61 | MP0002139_abnormal_hepatobiliary_system | 0.83506756 |
| 62 | MP0000609_abnormal_liver_physiology | 0.82647379 |
| 63 | MP0003690_abnormal_glial_cell | 0.82311119 |
| 64 | MP0008260_abnormal_autophagy | 0.81801827 |
| 65 | MP0010352_gastrointestinal_tract_polyps | 0.80557486 |
| 66 | MP0003045_fibrosis | 0.80361931 |
| 67 | MP0003936_abnormal_reproductive_system | 0.80123442 |
| 68 | MP0003075_altered_response_to | 0.78605385 |
| 69 | MP0001727_abnormal_embryo_implantation | 0.78149405 |
| 70 | MP0005535_abnormal_body_temperature | 0.76273528 |
| 71 | MP0001984_abnormal_olfaction | 0.75592018 |
| 72 | MP0004947_skin_inflammation | 0.73993781 |
| 73 | MP0001765_abnormal_ion_homeostasis | 0.73985511 |
| 74 | MP0001533_abnormal_skeleton_physiology | 0.73449756 |
| 75 | MP0009379_abnormal_foot_pigmentation | 0.73186845 |
| 76 | MP0003950_abnormal_plasma_membrane | 0.72632318 |
| 77 | MP0001849_ear_inflammation | 0.72599340 |
| 78 | MP0000613_abnormal_salivary_gland | 0.71708059 |
| 79 | MP0002168_other_aberrant_phenotype | 0.71208907 |
| 80 | MP0005220_abnormal_exocrine_pancreas | 0.71151622 |
| 81 | MP0005381_digestive/alimentary_phenotyp | 0.70346273 |
| 82 | MP0000343_altered_response_to | 0.69811922 |
| 83 | MP0002060_abnormal_skin_morphology | 0.68552183 |
| 84 | MP0005386_behavior/neurological_phenoty | 0.68493053 |
| 85 | MP0004924_abnormal_behavior | 0.68493053 |
| 86 | MP0009384_cardiac_valve_regurgitation | 0.66994771 |
| 87 | MP0005023_abnormal_wound_healing | 0.66954744 |
| 88 | MP0001958_emphysema | 0.66735890 |
| 89 | MP0005365_abnormal_bile_salt | 0.65487027 |
| 90 | MP0005332_abnormal_amino_acid | 0.65015251 |
| 91 | MP0000639_abnormal_adrenal_gland | 0.64344259 |
| 92 | MP0003453_abnormal_keratinocyte_physiol | 0.64187843 |
| 93 | MP0008770_decreased_survivor_rate | 0.64101444 |
| 94 | MP0001216_abnormal_epidermal_layer | 0.63895159 |
| 95 | MP0009643_abnormal_urine_homeostasis | 0.63658206 |
| 96 | MP0002166_altered_tumor_susceptibility | 0.63325805 |
| 97 | MP0002896_abnormal_bone_mineralization | 0.63196383 |
| 98 | MP0000490_abnormal_crypts_of | 0.62674590 |
| 99 | MP0003959_abnormal_lean_body | 0.62611655 |
| 100 | MP0002332_abnormal_exercise_endurance | 0.62096511 |
| 101 | MP0000750_abnormal_muscle_regeneration | 0.59353504 |
| 102 | MP0009115_abnormal_fat_cell | 0.57932346 |
| 103 | MP0005452_abnormal_adipose_tissue | 0.57826506 |
| 104 | MP0005636_abnormal_mineral_homeostasis | 0.57788310 |
| 105 | MP0005167_abnormal_blood-brain_barrier | 0.57572945 |
| 106 | MP0000858_altered_metastatic_potential | 0.56871438 |
| 107 | MP0004858_abnormal_nervous_system | 0.56644467 |
| 108 | MP0002078_abnormal_glucose_homeostasis | 0.56013384 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 0.55556050 |
| 110 | MP0006054_spinal_hemorrhage | 0.54109675 |
| 111 | MP0003828_pulmonary_edema | 0.53882307 |
| 112 | MP0001348_abnormal_lacrimal_gland | 0.52161269 |
| 113 | MP0002295_abnormal_pulmonary_circulatio | 0.51646467 |
| 114 | MP0003953_abnormal_hormone_level | 0.51345609 |
| 115 | MP0005165_increased_susceptibility_to | 0.49849875 |
| 116 | MP0009763_increased_sensitivity_to | 0.48975365 |
| 117 | MP0004883_abnormal_blood_vessel | 0.48914642 |
| 118 | MP0001545_abnormal_hematopoietic_system | 0.48530774 |
| 119 | MP0005397_hematopoietic_system_phenotyp | 0.48530774 |
| 120 | MP0000759_abnormal_skeletal_muscle | 0.48410286 |
| 121 | MP0002148_abnormal_hypersensitivity_rea | 0.48289467 |
| 122 | MP0001544_abnormal_cardiovascular_syste | 0.47506523 |
| 123 | MP0005385_cardiovascular_system_phenoty | 0.47506523 |
| 124 | MP0009931_abnormal_skin_appearance | 0.47432653 |
| 125 | MP0001177_atelectasis | 0.46721022 |
| 126 | MP0002282_abnormal_trachea_morphology | 0.44913361 |
| 127 | MP0002133_abnormal_respiratory_system | 0.43803751 |
| 128 | MP0003172_abnormal_lysosome_physiology | 0.43791993 |
| 129 | MP0002135_abnormal_kidney_morphology | 0.43559315 |
| 130 | MP0009642_abnormal_blood_homeostasis | 0.43245900 |
| 131 | MP0000371_diluted_coat_color | 0.36900434 |
| 132 | MP0009785_altered_susceptibility_to | 0.36842982 |
| 133 | MP0008789_abnormal_olfactory_epithelium | 0.36549905 |
| 134 | MP0004782_abnormal_surfactant_physiolog | 0.35557304 |
| 135 | MP0001756_abnormal_urination | 0.34622223 |
| 136 | MP0003195_calcinosis | 0.33708999 |
| 137 | MP0001542_abnormal_bone_strength | 0.32252223 |
| 138 | MP0008874_decreased_physiological_sensi | 0.31809876 |
| 139 | MP0005394_taste/olfaction_phenotype | 0.30828334 |
| 140 | MP0005499_abnormal_olfactory_system | 0.30828334 |
| 141 | MP0001764_abnormal_homeostasis | 0.30488527 |
| 142 | MP0000537_abnormal_urethra_morphology | 0.30235263 |
| 143 | MP0002089_abnormal_postnatal_growth/wei | 0.28399914 |
| 144 | MP0001853_heart_inflammation | 0.27561274 |
| 145 | MP0002693_abnormal_pancreas_physiology | 0.26169829 |
| 146 | MP0003638_abnormal_response/metabolism_ | 0.25281466 |
| 147 | MP0000598_abnormal_liver_morphology | 0.23545281 |
| 148 | MP0003315_abnormal_perineum_morphology | 0.22475729 |
| 149 | MP0002419_abnormal_innate_immunity | 0.21095469 |
| 150 | MP0003984_embryonic_growth_retardation | 0.20798466 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperactive renin-angiotensin system (HP:0000841) | 7.02907084 |
| 2 | Decreased circulating renin level (HP:0003351) | 6.77315428 |
| 3 | Abnormality of purine metabolism (HP:0004352) | 6.16181748 |
| 4 | Amelogenesis imperfecta (HP:0000705) | 5.33897561 |
| 5 | Axonal loss (HP:0003447) | 5.13054378 |
| 6 | Gout (HP:0001997) | 4.90352131 |
| 7 | Hypokalemic alkalosis (HP:0001949) | 4.58209596 |
| 8 | Congenital ichthyosiform erythroderma (HP:0007431) | 4.32453442 |
| 9 | Hyperkalemia (HP:0002153) | 4.08095098 |
| 10 | Thin bony cortex (HP:0002753) | 4.06129511 |
| 11 | Hyperlipoproteinemia (HP:0010980) | 4.04383444 |
| 12 | Overgrowth (HP:0001548) | 4.01176419 |
| 13 | Aortic aneurysm (HP:0004942) | 3.93716882 |
| 14 | Chronic bronchitis (HP:0004469) | 3.92498781 |
| 15 | Hydronephrosis (HP:0000126) | 3.91628262 |
| 16 | Pili torti (HP:0003777) | 3.86830871 |
| 17 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 3.77952706 |
| 18 | Hyperaldosteronism (HP:0000859) | 3.75864916 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 3.71780916 |
| 20 | Abnormality of nucleobase metabolism (HP:0010932) | 3.69707523 |
| 21 | Nephritis (HP:0000123) | 3.59186992 |
| 22 | Myocardial infarction (HP:0001658) | 3.52867995 |
| 23 | Symptomatic seizures (HP:0011145) | 3.43638334 |
| 24 | Stridor (HP:0010307) | 3.36444135 |
| 25 | Aortic dissection (HP:0002647) | 3.31344355 |
| 26 | Skin nodule (HP:0200036) | 3.26058133 |
| 27 | Hypotension (HP:0002615) | 3.22501017 |
| 28 | Cerebral aneurysm (HP:0004944) | 3.19024085 |
| 29 | Abnormality of renin-angiotensin system (HP:0000847) | 3.15326287 |
| 30 | Hyponatremia (HP:0002902) | 3.12683825 |
| 31 | Curly hair (HP:0002212) | 3.08841327 |
| 32 | Hyperuricemia (HP:0002149) | 3.03244586 |
| 33 | Increased purine levels (HP:0004368) | 3.03244586 |
| 34 | Metaphyseal irregularity (HP:0003025) | 3.00422895 |
| 35 | Abnormal tarsal ossification (HP:0008369) | 2.98283511 |
| 36 | Subcapsular cataract (HP:0000523) | 2.97806392 |
| 37 | Tubulointerstitial nephritis (HP:0001970) | 2.90173153 |
| 38 | Metaphyseal dysplasia (HP:0100255) | 2.89608572 |
| 39 | Abnormality of chloride homeostasis (HP:0011422) | 2.89174656 |
| 40 | Xanthomatosis (HP:0000991) | 2.89083666 |
| 41 | Abnormality of renal excretion (HP:0011036) | 2.88379369 |
| 42 | Protuberant abdomen (HP:0001538) | 2.87115683 |
| 43 | Atrophic scars (HP:0001075) | 2.84225498 |
| 44 | Enlarged epiphyses (HP:0010580) | 2.78252240 |
| 45 | Flat acetabular roof (HP:0003180) | 2.77749026 |
| 46 | Bone cyst (HP:0012062) | 2.77042431 |
| 47 | Neurodegeneration (HP:0002180) | 2.76011344 |
| 48 | Nausea (HP:0002018) | 2.69528283 |
| 49 | Tubulointerstitial fibrosis (HP:0005576) | 2.67778144 |
| 50 | Delayed epiphyseal ossification (HP:0002663) | 2.64066539 |
| 51 | Abnormality of renal resorption (HP:0011038) | 2.62748304 |
| 52 | Ectropion (HP:0000656) | 2.60498252 |
| 53 | Abnormality of sodium homeostasis (HP:0010931) | 2.54241852 |
| 54 | Glomerulosclerosis (HP:0000096) | 2.52820927 |
| 55 | Buphthalmos (HP:0000557) | 2.47140837 |
| 56 | Abnormal auditory evoked potentials (HP:0006958) | 2.47109137 |
| 57 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.45749474 |
| 58 | Onycholysis (HP:0001806) | 2.40564492 |
| 59 | Ketoacidosis (HP:0001993) | 2.39557728 |
| 60 | Deep venous thrombosis (HP:0002625) | 2.39354802 |
| 61 | Aneurysm (HP:0002617) | 2.39286574 |
| 62 | Turricephaly (HP:0000262) | 2.39089718 |
| 63 | Hyperparathyroidism (HP:0000843) | 2.36633470 |
| 64 | Adrenal overactivity (HP:0002717) | 2.34945106 |
| 65 | Abnormality of the nasal mucosa (HP:0000433) | 2.30565839 |
| 66 | Intrahepatic cholestasis (HP:0001406) | 2.29542360 |
| 67 | Hyperglycinuria (HP:0003108) | 2.29539394 |
| 68 | Rickets (HP:0002748) | 2.29150801 |
| 69 | Milia (HP:0001056) | 2.27126593 |
| 70 | Alkalosis (HP:0001948) | 2.26651567 |
| 71 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.26413875 |
| 72 | Hypoplasia of the iris (HP:0007676) | 2.25900737 |
| 73 | Asymmetry of the thorax (HP:0001555) | 2.22639185 |
| 74 | Abnormal hair laboratory examination (HP:0003328) | 2.22349540 |
| 75 | Hypoplasia of dental enamel (HP:0006297) | 2.17199963 |
| 76 | Abnormality of transition element cation homeostasis (HP:0011030) | 2.16588090 |
| 77 | Premature loss of primary teeth (HP:0006323) | 2.15583579 |
| 78 | Abnormal epiphyseal ossification (HP:0010656) | 2.14687429 |
| 79 | Renal salt wasting (HP:0000127) | 2.14577105 |
| 80 | Epiphyseal dysplasia (HP:0002656) | 2.13237246 |
| 81 | Vacuolated lymphocytes (HP:0001922) | 2.11530995 |
| 82 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.10414220 |
| 83 | Metabolic acidosis (HP:0001942) | 2.10195564 |
| 84 | Premature skin wrinkling (HP:0100678) | 2.08967422 |
| 85 | Long toe (HP:0010511) | 2.08879440 |
| 86 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.08798820 |
| 87 | Autoamputation (HP:0001218) | 2.07836482 |
| 88 | Hypercholesterolemia (HP:0003124) | 2.07102005 |
| 89 | Esophageal varix (HP:0002040) | 2.06597596 |
| 90 | Loss of speech (HP:0002371) | 2.06186861 |
| 91 | Abdominal distention (HP:0003270) | 2.05980628 |
| 92 | Osteolytic defects of the hand bones (HP:0009699) | 2.05808837 |
| 93 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.05808837 |
| 94 | Retrobulbar optic neuritis (HP:0100654) | 2.05452515 |
| 95 | Optic neuritis (HP:0100653) | 2.05452515 |
| 96 | Elevated alkaline phosphatase (HP:0003155) | 2.04903396 |
| 97 | Alopecia of scalp (HP:0002293) | 2.04706167 |
| 98 | Enlarged penis (HP:0000040) | 2.04393630 |
| 99 | Acanthosis nigricans (HP:0000956) | 2.03237992 |
| 100 | Difficulty running (HP:0009046) | 2.01975506 |
| 101 | Nephrolithiasis (HP:0000787) | 2.01968022 |
| 102 | Hyperglycinemia (HP:0002154) | 2.01836930 |
| 103 | Hypertriglyceridemia (HP:0002155) | 2.01645046 |
| 104 | Hepatosplenomegaly (HP:0001433) | 2.01148693 |
| 105 | Azoospermia (HP:0000027) | 2.00343333 |
| 106 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.99999526 |
| 107 | Glomerulonephritis (HP:0000099) | 1.99795823 |
| 108 | Nasal polyposis (HP:0100582) | 1.96771804 |
| 109 | Conjunctival hamartoma (HP:0100780) | 1.96326282 |
| 110 | Abnormality of dental color (HP:0011073) | 1.96304195 |
| 111 | Hematochezia (HP:0002573) | 1.96006169 |
| 112 | Hypokalemia (HP:0002900) | 1.94893105 |
| 113 | Abnormal hemoglobin (HP:0011902) | 1.93923018 |
| 114 | Arterial tortuosity (HP:0005116) | 1.92807191 |
| 115 | Fatigue (HP:0012378) | 1.92662021 |
| 116 | Polar cataract (HP:0010696) | 1.90684114 |
| 117 | Cortical dysplasia (HP:0002539) | 1.90262629 |
| 118 | Orchitis (HP:0100796) | 1.90159023 |
| 119 | Tetraparesis (HP:0002273) | 1.88623752 |
| 120 | Hypophosphatemia (HP:0002148) | 1.88031824 |
| 121 | Protrusio acetabuli (HP:0003179) | 1.86910421 |
| 122 | Wide cranial sutures (HP:0010537) | 1.85952944 |
| 123 | Ankle contracture (HP:0006466) | 1.84881132 |
| 124 | Widely patent fontanelles and sutures (HP:0004492) | 1.84447479 |
| 125 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.82589741 |
| 126 | Epiphyseal stippling (HP:0010655) | 1.82214444 |
| 127 | Oligomenorrhea (HP:0000876) | 1.81749539 |
| 128 | Vascular tortuosity (HP:0004948) | 1.81427370 |
| 129 | Paraparesis (HP:0002385) | 1.81103827 |
| 130 | Increased serum ferritin (HP:0003281) | 1.81027171 |
| 131 | Tubular atrophy (HP:0000092) | 1.80559186 |
| 132 | Abnormality of the dental pulp (HP:0006479) | 1.80426408 |
| 133 | Abnormality of the anterior chamber (HP:0000593) | 1.80101785 |
| 134 | Pancreatitis (HP:0001733) | 1.77988329 |
| 135 | Ketosis (HP:0001946) | 1.77915265 |
| 136 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.75859411 |
| 137 | Congenital glaucoma (HP:0001087) | 1.75774291 |
| 138 | Abnormality of the costochondral junction (HP:0000919) | 1.75008029 |
| 139 | Back pain (HP:0003418) | 1.73707042 |
| 140 | Striae distensae (HP:0001065) | 1.73568079 |
| 141 | Lymphangioma (HP:0100764) | 1.73403250 |
| 142 | Peripheral demyelination (HP:0011096) | 1.71874564 |
| 143 | Abnormality of the renal cortex (HP:0011035) | 1.71673078 |
| 144 | Abnormality of the periventricular white matter (HP:0002518) | 1.71164973 |
| 145 | Primary adrenal insufficiency (HP:0008207) | 1.71083168 |
| 146 | Epidermoid cyst (HP:0200040) | 1.70959007 |
| 147 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.70790713 |
| 148 | Abnormality of glycine metabolism (HP:0010895) | 1.70790713 |
| 149 | Poor eye contact (HP:0000817) | 1.70705594 |
| 150 | Biliary tract neoplasm (HP:0100574) | 1.70601151 |
| 151 | Spastic tetraparesis (HP:0001285) | 1.70183782 |
| 152 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.68065192 |
| 153 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.67371894 |
| 154 | Genu varum (HP:0002970) | 1.66021319 |
| 155 | Asymmetric septal hypertrophy (HP:0001670) | 1.65137235 |
| 156 | Flat occiput (HP:0005469) | 1.63487966 |
| 157 | Reduced antithrombin III activity (HP:0001976) | 1.62698966 |
| 158 | Dysostosis multiplex (HP:0000943) | 1.62547789 |
| 159 | Dehydration (HP:0001944) | 1.60956539 |
| 160 | Opisthotonus (HP:0002179) | 1.59049631 |
| 161 | Tubulointerstitial abnormality (HP:0001969) | 1.54417022 |
| 162 | Abnormal foot bone ossification (HP:0010675) | 1.51429867 |
| 163 | Ventricular fibrillation (HP:0001663) | 1.50847043 |
| 164 | Congenital sensorineural hearing impairment (HP:0008527) | 1.48008868 |
| 165 | Abnormality of potassium homeostasis (HP:0011042) | 1.47044067 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SIK1 | 5.47600780 |
| 2 | PKN2 | 4.87488190 |
| 3 | CAMK1D | 4.76128000 |
| 4 | TRIB3 | 4.17748204 |
| 5 | CAMK1G | 3.67385216 |
| 6 | ERN1 | 3.34256171 |
| 7 | EEF2K | 2.99816447 |
| 8 | ICK | 2.92095399 |
| 9 | MAP2K6 | 2.86343734 |
| 10 | PDK2 | 2.64229887 |
| 11 | ARAF | 2.54976642 |
| 12 | PTK6 | 2.51089780 |
| 13 | PDK4 | 2.45415260 |
| 14 | PDK3 | 2.45415260 |
| 15 | NME2 | 2.23212212 |
| 16 | BCKDK | 1.98857298 |
| 17 | PIK3CA | 1.97347163 |
| 18 | RIPK1 | 1.95618472 |
| 19 | EPHB1 | 1.95182902 |
| 20 | TGFBR2 | 1.93380203 |
| 21 | DAPK2 | 1.72876358 |
| 22 | MAPKAPK3 | 1.72258456 |
| 23 | MAP3K9 | 1.71955109 |
| 24 | MYLK | 1.71086201 |
| 25 | BMPR2 | 1.65016138 |
| 26 | PDGFRB | 1.58827076 |
| 27 | IRAK1 | 1.54723876 |
| 28 | LATS1 | 1.51184802 |
| 29 | TIE1 | 1.45054593 |
| 30 | EPHA3 | 1.42895783 |
| 31 | SCYL2 | 1.40206385 |
| 32 | ZAP70 | 1.37802630 |
| 33 | MOS | 1.34105273 |
| 34 | RET | 1.32307823 |
| 35 | BRAF | 1.31525647 |
| 36 | LRRK2 | 1.28308602 |
| 37 | PRKAA2 | 1.25429749 |
| 38 | MAP3K13 | 1.24087907 |
| 39 | TBK1 | 1.13478506 |
| 40 | FER | 1.11413350 |
| 41 | MAP3K7 | 1.08064245 |
| 42 | NLK | 1.07797738 |
| 43 | STK16 | 1.06909704 |
| 44 | MAP3K6 | 1.05203670 |
| 45 | MAPK12 | 0.96997220 |
| 46 | DDR2 | 0.96189611 |
| 47 | MAP3K14 | 0.95764525 |
| 48 | RPS6KB2 | 0.95298533 |
| 49 | PINK1 | 0.91962809 |
| 50 | TESK2 | 0.88710883 |
| 51 | STK38 | 0.88423322 |
| 52 | BMX | 0.87166113 |
| 53 | FGFR4 | 0.87107359 |
| 54 | JAK2 | 0.79819227 |
| 55 | MATK | 0.79198943 |
| 56 | JAK3 | 0.78381729 |
| 57 | RPS6KB1 | 0.75819384 |
| 58 | RIPK4 | 0.75729126 |
| 59 | STK39 | 0.74054404 |
| 60 | GSK3A | 0.73681562 |
| 61 | MAPKAPK5 | 0.72962753 |
| 62 | CAMK2D | 0.72931122 |
| 63 | PAK2 | 0.71791958 |
| 64 | SGK3 | 0.71621816 |
| 65 | PTK2 | 0.71390897 |
| 66 | LIMK1 | 0.70628306 |
| 67 | PIM1 | 0.66891874 |
| 68 | FRK | 0.66309367 |
| 69 | PIK3CG | 0.65547935 |
| 70 | IRAK4 | 0.64773493 |
| 71 | STK38L | 0.64228076 |
| 72 | CAMK2G | 0.63459869 |
| 73 | WNK4 | 0.63401044 |
| 74 | PRKCD | 0.62880130 |
| 75 | CDK9 | 0.61549865 |
| 76 | IRAK2 | 0.61507878 |
| 77 | PTK2B | 0.60985176 |
| 78 | TRPM7 | 0.58702976 |
| 79 | CAMK2B | 0.57698642 |
| 80 | JAK1 | 0.57315971 |
| 81 | MAP2K2 | 0.56316240 |
| 82 | KDR | 0.55533296 |
| 83 | IGF1R | 0.55404651 |
| 84 | TAOK2 | 0.54524752 |
| 85 | BCR | 0.54390253 |
| 86 | CAMK1 | 0.53320300 |
| 87 | TAOK1 | 0.52817192 |
| 88 | DAPK3 | 0.52476870 |
| 89 | PRKCG | 0.51923544 |
| 90 | MAP3K2 | 0.51717974 |
| 91 | EIF2AK1 | 0.51446995 |
| 92 | EPHB2 | 0.51240514 |
| 93 | MET | 0.48120567 |
| 94 | SGK494 | 0.47685980 |
| 95 | SGK223 | 0.47685980 |
| 96 | PDGFRA | 0.47445364 |
| 97 | GRK7 | 0.46911262 |
| 98 | MAP3K3 | 0.46296676 |
| 99 | ILK | 0.46190245 |
| 100 | PRKAA1 | 0.46041927 |
| 101 | SGK2 | 0.43426365 |
| 102 | TAOK3 | 0.43049058 |
| 103 | TYRO3 | 0.41780166 |
| 104 | RPS6KA2 | 0.40899578 |
| 105 | LMTK2 | 0.39125251 |
| 106 | CHUK | 0.37947451 |
| 107 | PRKD1 | 0.37550697 |
| 108 | LATS2 | 0.37081401 |
| 109 | MTOR | 0.36388093 |
| 110 | PDPK1 | 0.35680926 |
| 111 | DYRK2 | 0.34829878 |
| 112 | NEK6 | 0.34411885 |
| 113 | EIF2AK2 | 0.33830879 |
| 114 | EIF2AK3 | 0.33004532 |
| 115 | TESK1 | 0.32833630 |
| 116 | SRC | 0.32676416 |
| 117 | IKBKE | 0.32672173 |
| 118 | PAK4 | 0.32220347 |
| 119 | TTN | 0.32053884 |
| 120 | PDK1 | 0.31510072 |
| 121 | FGFR3 | 0.31493471 |
| 122 | MAP2K1 | 0.30957088 |
| 123 | FGR | 0.29795381 |
| 124 | CAMKK1 | 0.29299619 |
| 125 | CSK | 0.28335069 |
| 126 | KSR2 | 0.28275825 |
| 127 | RAF1 | 0.28153154 |
| 128 | MAPK11 | 0.27324547 |
| 129 | FLT3 | 0.27094936 |
| 130 | TYK2 | 0.26516180 |
| 131 | EGFR | 0.26135527 |
| 132 | CSF1R | 0.26043287 |
| 133 | MAP3K1 | 0.24268090 |
| 134 | CDK6 | 0.23863911 |
| 135 | LYN | 0.22067506 |
| 136 | NTRK3 | 0.21936514 |
| 137 | STK3 | 0.21795815 |
| 138 | PRKACG | 0.21568402 |
| 139 | DAPK1 | 0.21565197 |
| 140 | ERBB3 | 0.21426480 |
| 141 | PRKCZ | 0.21402995 |
| 142 | INSR | 0.21176361 |
| 143 | MAPK4 | 0.20400977 |
| 144 | GRK6 | 0.19114141 |
| 145 | BTK | 0.18580995 |
| 146 | IRAK3 | 0.17393051 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 8.71027661 |
| 2 | Caffeine metabolism_Homo sapiens_hsa00232 | 8.62855534 |
| 3 | Galactose metabolism_Homo sapiens_hsa00052 | 3.20910525 |
| 4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.10495111 |
| 5 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.54882117 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.23074824 |
| 7 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.19154524 |
| 8 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.02104364 |
| 9 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.65579454 |
| 10 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.59502794 |
| 11 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.52174084 |
| 12 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.49520929 |
| 13 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.27752786 |
| 14 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.22600939 |
| 15 | * Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.19689476 |
| 16 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.12211694 |
| 17 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.10656339 |
| 18 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.05080659 |
| 19 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.03258527 |
| 20 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.99573967 |
| 21 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.92851700 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.91835691 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 0.89268129 |
| 24 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.84538062 |
| 25 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.83528500 |
| 26 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.82128718 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 0.80238960 |
| 28 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.78419215 |
| 29 | Protein export_Homo sapiens_hsa03060 | 0.71189626 |
| 30 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.71095019 |
| 31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.69299629 |
| 32 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68491470 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 0.68046166 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62832984 |
| 35 | Histidine metabolism_Homo sapiens_hsa00340 | 0.61413501 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.61295033 |
| 37 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.60093006 |
| 38 | Amoebiasis_Homo sapiens_hsa05146 | 0.58521546 |
| 39 | Sulfur relay system_Homo sapiens_hsa04122 | 0.55902062 |
| 40 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.52301282 |
| 41 | Hepatitis C_Homo sapiens_hsa05160 | 0.51478906 |
| 42 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.49585882 |
| 43 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.48668958 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.48447063 |
| 45 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.47200634 |
| 46 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.46976085 |
| 47 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.46843819 |
| 48 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.45639740 |
| 49 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44444846 |
| 50 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44125980 |
| 51 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.43734153 |
| 52 | Malaria_Homo sapiens_hsa05144 | 0.43236208 |
| 53 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.42752202 |
| 54 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.42025713 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.42023838 |
| 56 | Tight junction_Homo sapiens_hsa04530 | 0.41523628 |
| 57 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.41353939 |
| 58 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.41333319 |
| 59 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.39515542 |
| 60 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38851015 |
| 61 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.38325300 |
| 62 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.38076331 |
| 63 | Focal adhesion_Homo sapiens_hsa04510 | 0.37808857 |
| 64 | Legionellosis_Homo sapiens_hsa05134 | 0.36556756 |
| 65 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.36488868 |
| 66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.35873001 |
| 67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.34294169 |
| 68 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.34053156 |
| 69 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.33793412 |
| 70 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.33437265 |
| 71 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33254012 |
| 72 | Endocytosis_Homo sapiens_hsa04144 | 0.32882548 |
| 73 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.31992134 |
| 74 | Leishmaniasis_Homo sapiens_hsa05140 | 0.31924271 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.31857862 |
| 76 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.31766818 |
| 77 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.31632962 |
| 78 | Bile secretion_Homo sapiens_hsa04976 | 0.30492644 |
| 79 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.30341461 |
| 80 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.30268693 |
| 81 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.29298029 |
| 82 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.29291578 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.29127485 |
| 84 | Bladder cancer_Homo sapiens_hsa05219 | 0.29008596 |
| 85 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.28791742 |
| 86 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.28601619 |
| 87 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.28571325 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.28076191 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.27364019 |
| 90 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.26891414 |
| 91 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.26397934 |
| 92 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.25763517 |
| 93 | Purine metabolism_Homo sapiens_hsa00230 | 0.24186481 |
| 94 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24108630 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.24014212 |
| 96 | Metabolic pathways_Homo sapiens_hsa01100 | 0.23700257 |
| 97 | Lysosome_Homo sapiens_hsa04142 | 0.23039820 |
| 98 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.22259950 |
| 99 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.20546559 |
| 100 | Thyroid cancer_Homo sapiens_hsa05216 | 0.20278706 |
| 101 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.20058068 |
| 102 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.19742411 |
| 103 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.19448339 |
| 104 | Phagosome_Homo sapiens_hsa04145 | 0.19411592 |
| 105 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.17929985 |
| 106 | Hepatitis B_Homo sapiens_hsa05161 | 0.17333922 |
| 107 | Adherens junction_Homo sapiens_hsa04520 | 0.16690895 |
| 108 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.16640629 |
| 109 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.16532098 |
| 110 | Tuberculosis_Homo sapiens_hsa05152 | 0.16531952 |
| 111 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.16418133 |
| 112 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15651403 |
| 113 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.15345096 |
| 114 | Colorectal cancer_Homo sapiens_hsa05210 | 0.15019492 |
| 115 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.14728823 |
| 116 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.13788850 |
| 117 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.13725815 |
| 118 | Salivary secretion_Homo sapiens_hsa04970 | 0.13115067 |
| 119 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.12763685 |
| 120 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.12665845 |
| 121 | Mineral absorption_Homo sapiens_hsa04978 | 0.12569468 |
| 122 | Pertussis_Homo sapiens_hsa05133 | 0.11631404 |
| 123 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.11210247 |
| 124 | Renin secretion_Homo sapiens_hsa04924 | 0.09974783 |
| 125 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.09316726 |
| 126 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.03485989 |
| 127 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.02719098 |
| 128 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.02496289 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.02328134 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.01853028 |
| 131 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.0696471 |
| 132 | Choline metabolism in cancer_Homo sapiens_hsa05231 | -0.0651248 |
| 133 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0486000 |
| 134 | Estrogen signaling pathway_Homo sapiens_hsa04915 | -0.0375522 |
| 135 | Cholinergic synapse_Homo sapiens_hsa04725 | -0.0352382 |
| 136 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | -0.0237320 |
| 137 | GnRH signaling pathway_Homo sapiens_hsa04912 | -0.0180995 |

